http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1801679_PMID

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID164038954_AID1801679_PMID_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID164038955_AID1801679_PMID_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID164038956_AID1801679_PMID_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID313634255_AID1801679_PMID_VALUE4
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35372
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title Mu-Opioid GTPgammaS Binding Assay from US Patent US9145408: \"Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators\"
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID164038955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID164038956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID313634255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID164038954
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1801679

Total number of triples: 13.